Sanjoy Datta

1.1k total citations
20 papers, 764 citations indexed

About

Sanjoy Datta is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Sanjoy Datta has authored 20 papers receiving a total of 764 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 7 papers in Infectious Diseases and 7 papers in Surgery. Recurrent topics in Sanjoy Datta's work include Cervical Cancer and HPV Research (9 papers), Hepatitis B Virus Studies (9 papers) and Genital Health and Disease (6 papers). Sanjoy Datta is often cited by papers focused on Cervical Cancer and HPV Research (9 papers), Hepatitis B Virus Studies (9 papers) and Genital Health and Disease (6 papers). Sanjoy Datta collaborates with scholars based in Belgium, India and United Kingdom. Sanjoy Datta's co-authors include Dominique Descamps, Hans L. Bock, Nahida Chakhtoura, Mark H. Einstein, Myron J. Levin, Jeffrey B. Rosen, Archana Chatterjee, Mira Baron, Gary Dubin and Yves Buisson and has published in prestigious journals such as International Journal of Cancer, Vaccine and World Journal of Gastroenterology.

In The Last Decade

Sanjoy Datta

20 papers receiving 736 citations

Peers

Countries citing papers authored by Sanjoy Datta

Since Specialization

Citations

This map shows the geographic impact of Sanjoy Datta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanjoy Datta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanjoy Datta more than expected).

Fields of papers citing papers by Sanjoy Datta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sanjoy Datta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanjoy Datta. The network helps show where Sanjoy Datta may publish in the future.

Co-authorship network of co-authors of Sanjoy Datta

This figure shows the co-authorship network connecting the top 25 collaborators of Sanjoy Datta. A scholar is included among the top collaborators of Sanjoy Datta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sanjoy Datta. Sanjoy Datta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of vaccines on antimicrobial resistance 2019 ·International Journal of Infectious Diseases ·Philippe Buchy, Sibel Aşçıoğlu, Yves Buisson, Sanjoy Datta, Michael D. Nissen, Paul Anantharajah Tambyah, Sirenda Vong	108
2	Safety of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in adolescents aged 12–15 years: Interim analysis of a large community-randomized controlled trial 2016 ·Human Vaccines & Immunotherapeutics ·Matti Lehtinen, Tiina Eriksson, Dan Apter, Mari Hokkanen, Kari Natunen, Jorma Paavonen, Eero Pukkala, (unknown), (unknown), Marie‐Pierre David, Sanjoy Datta, Dan Bi, Frank Struyf, Gary Dubin	22
3	Characteristics of a cluster-randomized phase IV human papillomavirus vaccination effectiveness trial 2015 ·Vaccine ·Matti Lehtinen, Dan Apter, Iacopo Baussano, Tiina Eriksson, Kari Natunen, Jorma Paavonen, Simopekka Vänskä, Dan Bi, Marie‐Pierre David, Sanjoy Datta, Frank Struyf, David Jenkins, Eero Pukkala, Geoff P. Garnett, Gary Dubin	39
4	Immunogenicity and safety of early vaccination with two doses of a combined measles-mumps-rubella-varicella vaccine in healthy Indian children from 9 months of age: a phase III, randomised, non-inferiority trial 2015 ·BMJ Open ·Sanjay Lalwani, Sukanta Chatterjee, Sundaram Balasubramanian, Ashish Bavdekar, (unknown), Sanjoy Datta, Michael Povey, Ouzama Henry	15
5	Hepatotropic viruses as etiological agents of acute liver failure and related-outcomes among children in India: a retrospective hospital-based study 2015 ·BMC Research Notes ·Anand Pandit, Leni G. Mathew, Ashish Bavdekar, (unknown), Gunasekaran Ramakrishnan, Sanjoy Datta, Yan Fang Liu	9
6	Human papillomavirus prevalence and type-distribution in women with cervical lesions: a cross-sectional study in Sri Lanka 2014 ·BMC Cancer ·Kanishka Karunaratne, (unknown), (unknown), Anco Molijn, Kusuma Gopala, Johannes Schmidt, Jing Chen, Sanjoy Datta, (unknown)	9
7	Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chinese girls and women aged 9 to 45 years 2014 ·Human Vaccines & Immunotherapeutics ·Fengcai Zhu, Juan Li, Yuemei Hu, Xiang Zhang, Xiaoping Yang, Hui Zhao, Junzhi Wang, (unknown), (unknown), (unknown), Haïwen Tang, P.V. Suryakiran, Sanjoy Datta, Dominique Descamps, Dan Bi, Frank Struyf	21
8	Baseline prevalence and type distribution of human papillomavirus in healthy Chinese women aged 18–25 years enrolled in a clinical trial 2014 ·International Journal of Cancer ·Fanghui Zhao, Fengcai Zhu, Wen Chen, Juan Li, Yuemei Hu, Ying Hong, Yiju Zhang, Qinjing Pan, Jiahong Zhu, (unknown), Yong Chen, Haïwen Tang, Baiyu Zhang, Christelle Durand, Sanjoy Datta, Frank Struyf, Dan Bi, (unknown)	24
9	Safety and immunogenicity of human papillomavirus-16/18 AS04-adjuvanted vaccine in healthy Chinese females aged 15 to 45 years: a phase I trial 2011 ·Chinese Journal of Cancer ·Fengcai Zhu, Changgui Li, Hongxing Pan, Yiju Zhang, Dan Bi, Haïwen Tang, Sanjoy Datta	6
10	Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 vaccine and HPV-6/11/16/18 vaccine 2011 ·Human Vaccines ·Mark H. Einstein, Mira Baron, Myron J. Levin, Archana Chatterjee, (unknown), (unknown), Jeffrey B. Rosen, Nahida Chakhtoura, (unknown), Francis Dessy, Sanjoy Datta, Dominique Descamps, Gary Dubin	136
11	Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18–45 years 2011 ·Human Vaccines ·Mark H. Einstein, Mira Baron, Myron J. Levin, Archana Chatterjee, (unknown), (unknown), Jeffrey B. Rosen, Nahida Chakhtoura, (unknown), Robbert van der Most, Philippe Moris, Sandra L. Giannini, Anne Schuind, Sanjoy Datta, Dominique Descamps	90
12	The immunogenicity and safety of a reduced PRP-content DTPw-HBV/Hib vaccine when administered according to the accelerated EPI schedule 2010 ·BMC Infectious Diseases ·Sukanta Chatterjee, (unknown), (unknown), B. D. Bhatia, Alix Collard, Sanjoy Datta, Jeanne‐Marie Jacquet	12
13	Immunogenicity and safety of human papillomavirus‐16/18 AS04‐adjuvanted cervical cancer vaccine in healthy Indian women 2010 ·Journal of obstetrics and gynaecology research ·Neerja Bhatla, Vanita Suri, Partha Basu, Surendra S. Shastri, Sanjoy Datta, Dan Bi, Dominique Descamps, Hans L. Bock, (unknown)	42
14	Successful co-administration of a human rotavirus and oral poliovirus vaccines in Bangladeshi infants in a 2-dose schedule at 12 and 16 weeks of age 2009 ·Vaccine ·Khalequ Zaman, David A. Sack, Mohammad Yunus, Shams El Arifeen, Goutam Podder, Tasnim Azim, Stephen P. Luby, Robert F. Breiman, Kathleen M. Neuzil, Sanjoy Datta, A. Delem, P.V. Suryakiran, H.L. Bock	90
15	Women and vaccinations: From smallpox to the future, a tribute to a partnership benefiting humanity for over 200 years 2009 ·Human Vaccines ·Sanjoy Datta, Neerja Bhatla, Margaret Burgess, Matti Lehtinen, Hans L. Bock	2
16	Immunogenicity, reactogenicity and safety of human rotavirus vaccine (RIX4414) in Indian infants 2009 ·Human Vaccines ·Anil Narang, Anuradha Bose, A N Pandit, Phalguni Dutta, Gagandeep Kang, Sujit Bhattacharya, Sanjoy Datta, (unknown), A. Delem, Htay Htay Han, Hans L. Bock	60
17	Community-based cross-sectional seroprevalence study of hepatitis A in Bangladesh 2009 ·World Journal of Gastroenterology ·Samir K. Saha, (unknown), (unknown), Mohammed Hanif, Md. Ahsan Habib, Sanjoy Datta, Hans L. Bock	24
18	Retrospective Surveillance for Intussusception in Children Aged Less than Five Years in a South Indian Tertiary-care Hospital 2009 ·Journal of Health Population and Nutrition ·Sanjoy Datta, Kaushik Bhowmick, Gagandeep Kang, Anuradha Bose, Jacob Chacko, Irving Charles Boudville, Hans L. Bock	28
19	Immunogenicity, Reactogenicity and Safety of a Diphtheria-Tetanus-Acellular Pertussis-Inactivated Polio and Haemophilus Influenzae Type b Combination Vaccine in a Placebo-controlled Rotavirus Vaccine Study 2008 ·Annals of the Academy of Medicine Singapore ·Kong Boo Phua, Seng Hock Quak, Fong Seng Lim, P. Goh, Yee Leong Teoh, Sanjoy Datta, Htay Htay Han, Hans L. Bock	20
20	Safety and reactogenicity of a low dose diphtheria tetanus acellular pertussis vaccine (Boostrix) in pre-school Indian children. 2007 ·PubMed ·Anuradha Bose, Anand Prakash Dubey, (unknown), Anand Pandit, Maithra Raghu, P. Raghupathy, (unknown), Valsan Philip Verghese, Sanjoy Datta, H.L. Bock	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact